15.11.2024  22:58:58 Zm. -3,000 Wolumen Bid22:58:58 Ask22:58:58 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
142,550EUR -2,06% -
Obrót: -
142,550Wolumen Bid: - 143,950Wolumen Ask: - 18,62 mldEUR 1,53% 22,20

Opis działalności

Merck is a leading science and technology company in healthcare, life science and performance materials. Around 52,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck, Darmstadt, Germany holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.
 

Zarząd & Rada nadzorcza

CEO
Belén Garijo
Zarząd
Marcus Kuhnert, Dr. Kai Beckmann, Matthias Heinzel, Peter Guenter
Rada nadzorcza
Dr. Wolfgang Büchele, Sascha Held, Alexander Putz, Anne Lange, Christian Raabe, Daniel Thelen, Dietmar Oeter, Gabriele Eismann, Helene von Roeder, Helga Rübsamen-Schaeff, Jürgen Glaser, Michael Kleinemeier, Peter Emanuel Merck, Renate Koehler, Simon Thelen, Birgit Biermann
 

Dane firmy

Nazwa: Merck KGaA
Adres: Frankfurter Str. 250,D-64293 Darmstadt
Telefon: +49-6151-72-0
Fax: +49-6151-72-2000
E-mail: service@merckgroup.com
Internet: www.merck.de
Przemysł: Służba zdrowia
Sektor: Przemysł Farmaceutyczny
Podsektor: Przemysł Farmaceutyczny
Koniec roku finansowego: 31.12
Free float: 66,28%
Data IPO: 20.10.1995

Relacje inwestorskie

Nazwa: Constantin Fest
Telefon: +49-6151-72-3321
Fax: +49-6151-72-91-3321
E-mail: investor.relations@m...oup.com investor.relations@merckgroup.com

Główni akcjonariusze

Inne
 
73,64%
BlackRock, Inc.
 
7,43%
Massachusetts Financial Services Company
 
5,06%
Sun Life Financial Inc.
 
4,91%
FMR LLC
 
3,02%
Amundi S.A.
 
2,99%
DWS Investment GmbH
 
2,95%